PRODUCTS
Product name: Avanafil
Cas NO: 330784-47-9
M.F: C23H26ClN7O3
M.W:483.95
Capacity: 500KG/M
Usage: Sexual Enhancement
■ Description
Avanafil is a highly selective oral phosphodiesterase 5 inhibitor. Phase I, II, and III clinical trials have shown that compared with other chemicalbook phosphodiesterase 5 inhibitors, avanafil has the characteristics of rapid onset, short duration of action, fewer adverse reactions, and good clinical efficacy and safety in the treatment of erectile dysfunction.
Avanafil is a PDE5 inhibitor that was approved by the FDA on April 27, 2012 for the treatment of erectile dysfunction. Avanafil works by inhibiting a specific phosphodiesterase type 5 enzyme found in various body tissues, primarily in the corpus cavernosum. Other similar drugs are sildenafil, tadalafil, and vardenafil. The advantage of avanafil is that it has a very rapid onset of action compared to other PDE5 inhibitors. It is rapidly absorbed, reaching maximum serum concentrations in about thirty to forty-five minutes. About two-thirds of the participants were able to engage in sexual activity within fifteen minutes.
■ Message
Related Products
Leave A Message
If you are interested in our products and want to know more details, please leave a message here, we will reply you as soon as we can.